Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
Original Article
V. Minard-Colin, A. Aupérin, M. Pillon, G.A. Burke, D.A. Barkauskas, K. Wheatley, R.F. Delgado, S. Alexander, A. Uyttebroeck, C.M. Bollard, J. Zsiros, M. Csoka, B. Kazanowska, A.K. Chiang, R.R. Miles, A. Wotherspoon, P.C. Adamson, G. Vassal, C. Patte, and T.G. Gross
N Engl J Med 2020;382:2207-2219
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, June 4, 2022 - 11:59pm.